Glomerular aging and focal global glomerulosclerosis: A podometric perspective

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 3162-3178

  Hodgin, Jeffrey B ^a   Bitzer, Markus ^a   Wickman, Larysa ^b   Afshinnia, Farsad ^a   Wang, Su Q ^a   O'Connor, Christopher ^a   Yang, Yan ^a   Meadowbrooke, Chrysta ^b   Chowdhury, Mahboob ^a   Kikuchi, Masao ^a   Wiggins, Jocelyn E ^a   Wiggins, Roger C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CELL COUNT; CELL DENSITY; CELL VOLUME; CHILD; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; FOCAL GLOBAL GLOMERULOSCLEROSIS; GLOMERULAR AGING; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY HYPERTROPHY; MALE; NEPHRECTOMY; PODOCYTE; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; AGE; CELL NUCLEUS; FOCAL GLOMERULOSCLEROSIS; HYPERTROPHY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CELL COUNT; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYPERTROPHY; MIDDLE AGED; ORGAN SIZE; PODOCYTES; YOUNG ADULT;

EID: 84953331151     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014080752     Document Type: Article

References (52)

1. Councilman WT: The conditions presented in the heart and kidneys of old people. In: Contributions to Medical and Biological Research, Dedicated to Sir William Osler on His 70th Birthday, New York, 1919, pp. 918-928
2. Kaplan C, Pasternack B, Shah H, Gallo G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80: 227-234, 1975
3. McLachlan MSF: The ageing kidney. Lancet 2: 143-145, 1978
4. Smith SM, Hoy WE, Cobb L: Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113: 1253-1255, 1989
5. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD: The association between age and nephrosclerosis on renal biopsy among healthy adults.Ann InternMed 152: 561-567, 2010
6. Glassock RJ, Rule AD: The implications of anatomical and functional changes of the aging kidney: With an emphasis on the glomeruli. Kidney Int 82: 270-277, 2012
7. Davies DF, Shock NW: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adultmales. J Clin Invest 29: 496-507, 1950
8. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285, 1985
9. Fliser D, Franek E, Ritz E: Renal function in the elderly-is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transplant 12: 1553-1555, 1997
10. National Institute of Diabetes and Digestive and Kidney Diseases: Information Clearinghouse (NKUDIC) Available at: http://www.niddk.nih. gov/KUDiseases/pubs/kustats/#1. Accessed March 17, 2015
11. United States Organ Procurement and Transplant Network and Scientific Registry of Transplant Recipients (OPTN/SRTR) Annual Data Report, 2012. Available at http://srtr.transplant.hrsa.gov/annual-reports/2012/pdf/2012-SRTR-ADR.pdf. Accessed March 17, 2015
12. Kim YH, Goyal M, Kurnit D, WharramB,Wiggins J, Holzman L, Kershaw D,Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001
13. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
14. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC: Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012
15. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC: Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 23: 1351-1363, 2012
16. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54: 687-697, 1998
17. Kriz W: Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57: 189-195, 2002
18. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
19. Wiggins RC: The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
20. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. JClin Invest 99: 342-348, 1997
21. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts longterm urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999
22. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001
23. White KE, Bilous RW,Marshall SM, El NahasM, Remuzzi G, Piras G, De Cosmo S, Viberti G: European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT): Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 51: 3083-3089, 2002
24. Lemley KV, Lafayette RA, SafaiM, Derby G, Blouch K, Squarer A,Myers BD: Podocytopenia and disease severity in IgAnephropathy. Kidney Int 61: 1475-1485, 2002
25. Dalla VestraM, Masiero A, Roiter AM, Saller A, CrepaldiG, Fioretto P: Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035, 2003
26. WangG, Lai FM, Kwan BC, Lai KB, ChowKM, Li PK, Szeto CC: Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 22: 300-306, 2009
27. Yang Y, Hodgin JB, Afshinnia F, Wang SQ, Wickman L, Chowdhury M, Nishizono R, Kikuchi M, Huang Y, Samaniego M, Wiggins RC: The two kidney to one kidney transition and transplant glomerulopathy: A podocyte perspective [published online ahead of print November 11, 2014]. J Am Soc Nephrol doi: 10.1681/ASN.2014030287
28. Wiggins JE, GoyalM, Sanden SK,WharramBL, Shedden KA,Misek DE, Kuick RD, Wiggins RC: Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005
29. Venkatareddy M, Wang S, Yang Y, Patel S, Wickman L, Nishizono R, Chowdhury M, Hodgin J, Wiggins PA, Wiggins RC: Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol 25: 1118-1129, 2014
30. Huber MD, Gerace L: The size-wise nucleus: Nuclear volume control in eukaryotes. J Cell Biol 179: 583-584, 2007
31. Cavalier-Smith T: Economy, speed and size matter: Evolutionary forces driving nuclear genome miniaturization and expansion. Ann Bot (Lond) 95: 147-175, 2005
32. Fukuda A,Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC: Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Nephrol Dial Transplant 27: 4079-4087, 2012
33. Lasagni L, Lazzeri E, Shankland SJ, Anders H-J, Romagnani P: Podocyte mitosis-a catastrophe. Curr Mol Med 13: 13-23, 2013
34. Helmchen U, Wenzel UO: Benign and malignant nephrosclerosis and renovascular disease. In: Renal Pathology. With Clinical and Functional Correlations, Volume II, edited by TisherCC, Brenner BM, Philadelphia, J.B. Lippincott, 1994, pp. 1201-1236.
35. HaraM, Yanagihara T, Hirayama Y,Ogasawara S, Kurosawa H, Sekine S, Kihara I: Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 41: 1265-1275, 2010
36. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J Am Soc Nephrol 16: 408-416, 2005
37. Hara M, Yanagihara T, Kihara I: Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347, 2001
38. Vogelmann SU, NelsonWJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 285: F40-F48, 2003
39. Stokes MB, D'Agati VD: Morphologic variants of focal segmental glomerulosclerosis and their significance. Adv Chronic Kidney Dis 21: 400-407, 2014
40. Valeri A, Barisoni L, AppelGB, SeigleR, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996
41. Cho CR, Lumsden CJ, Whiteside CI: Epithelial cell detachment in the nephrotic glomerulus: A receptor co-operativity model. J Theor Biol 160: 407-426, 1993
42. Ichikawa I, Ma J, Motojima M, Matsusaka T: Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 14: 205-210, 2005
43. Cui S, Guo G, Li C,Willecke K, Quaggin SE: Innocent bystander theory for progression to glomerulosclerosis in a transgenic mouse model [Abstract]. J Am Soc Nephrol 15: 241A, 2004
44. Wiggins JE, Patel S, Shedden K, Goyal M, Wharram B,Martini S, Kretzler M, Wiggins RC: NfkappaB promotes inflammation, coagulation, and fibrosisin the aging glomerulus. J AmSocNephrol 21: 587-597, 2010
45. Shapiro P: Malignant nephrosclerosis. Transactions of the Chicago Pathological Society 13: 353-391, 1931
46. Pamukcu B, Lip GY, Shantsila E: The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res 128: 117-123, 2011
47. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia: Vascular contributions to cognitive impairment anddementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke 42: 2672-2713, 2011
48. Striker G: Introduction to the aging kidney. J Gerontol A Biol Sci Med Sci 67: 1341-1342, 2012
49. WannerN,Hartleben B, HerbachN,GoedelM, Stickel N, Zeiser R,Walz G, Moeller MJ, Grahammer F, Huber TB: Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 25: 707-716, 2014
50. Weibel ER: Stereologic Methods: Practical Methods for Biologic Morphometry, London, Academic Press, 1979, pp. 40-116, 415
51. SharmaM, Fopma A, Brantley JG, Vanden Heuvel GB: Coexpression of Cux-1 and Notch signaling pathway components during kidney development. Dev Dyn 231: 828-838, 2004
52. Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC: Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 24: 2081-2095, 2013